Glaucoma Open-angle
📧 Sign up to get email alerts when something new happens for Glaucoma Open-angle.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Comparison of Effect of Postoperative Cyclosporine A 2% Ophthalmic Emulsion and Betamethasone Eye Drop on Surgical Success of Trabeculectomy Procedure [Phase 2]
This Phase 2 clinical trial compared postoperative cyclosporine A 2% ophthalmic emulsion to betamethasone eye drops for surgical success aft…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle Glaucoma
Clinical trial update evaluating the rate of progression in newly diagnosed open-angle glaucoma using perimetry, with ocular hypertension as…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Treatment of Failing Blebs With Ranibizumab [Phase 1]
Phase 1 clinical trial evaluating ranibizumab for treatment of failing blebs after trabeculectomy in open-angle glaucoma; the study has comp…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction [Phase 4]
Phase 4 trial assessing safety and efficacy of LUMIGAN RC versus DuoTrav in patients needing further intraocular pressure reduction; results…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension [Phase 4]
Phase 4 clinical trial update for bimatoprost in primary open-angle glaucoma and ocular hypertension completed with results posted in 2014.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Completed clinical trial evaluating Lumigan 0.01% in primary open-angle glaucoma or ocular hypertension has posted results (2014-06-13).
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 study evaluating the efficacy and safety of once-daily instillation of a combination glaucoma therapy in adults with open-angle gl…
-
CLINICAL_TRIALS trial_result · 2011-06-01Clinical Trial Update: Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma
An internet-based, naturalistic evaluation of tolerability for bimatoprost 0.03% in open-angle glaucoma has been completed, providing real-w…
-
CLINICAL_TRIALS trial_result · 2009-09-22Clinical Trial Update: Search for Biomarkers in Human Glaucoma: Lymphocytes Alterations and Rate of Progression
A completed University of Parma study investigated lymphocyte biomarkers and the rate of progression in open-angle glaucoma.
-
CLINICAL_TRIALS trial_result · 2009-07-16Clinical Trial Update: Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®
Non-interventional study in open-angle glaucoma and/or ocular hypertension treated with XALATAN (latanoprost) completed; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Phase 3]
A Phase 3 head-to-head trial comparing Travoprost 0.004% with Latanoprost 0.005% in open-angle glaucoma and ocular hypertension has complete…
-
CLINICAL_TRIALS trial_result · 2008-06-30Clinical Trial Update: Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes
A completed clinical trial from the Medical University of Vienna studied circadian variations in ocular blood flow in glaucomatous and norma…